3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Virus Diseases
1
Tumor Virus Infections
1
Squamous Cell Carcinoma of Head and Neck
1
Pharyngeal Diseases
1
Papillomavirus Infections
1
Otorhinolaryngologic Neoplasms
1
Otorhinolaryngologic Diseases
1
Oropharyngeal Neoplasms
1
Neoplasms, Squamous Cell
1
Neoplasms, Glandular and Epithelial
1
Neoplasms by Site
1
Neoplasms by Histologic Type
1
Head and Neck Neoplasms
1
DNA Virus Infections
1
Carcinoma, Squamous Cell
1
Carcinoma
1
Interventions
Cisplatin
5
pembrolizumab
4
Surveys and Questionnaires
2
Radiotherapy
2
N-benzhydryl-5-(2-(methylamino)propanamido)-3-(3-methylbutanoyl)-6-oxodecahydropyrrolo(1,2-a)(1,5)diazocine-8-carboxamide
2
Fluorouracil
2
Docetaxel
2
Cetuximab
2
niraparib
1
monalizumab
1
linrodostat
1
durvalumab
1
dostarlimab
1
Tablets
1
Surgical Flaps
1
Radiotherapy, Intensity-Modulated
1
Radiation
1
Nivolumab
1
LY2940680
1
Interviews as Topic
1
Combined Modality Therapy
1
Chemical Fractionation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Laryngeal Diseases
×
Nimorazole
×
1 year
×
Clear all
No trials found.